Barely Significant
← all excerpts

Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia.

PLoS One · 2011 · PMC3202542 · PMID 22046290

Europe PMCDOI
1
hedged sentence
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

did not reach statistical significancep = 0.1so close (0.05 < p ≤ 0.1)
Use of combination therapy was found to be associated with higher proportions of treatment success in univariable analysis compared to beta-lactam monotherapy [29/34 (85%) in combination versus 13/20 (65%) in monotherapy], however this did not reach statistical significance [odds ratio (OR) 3.1; 95% Confidence Interval (CI) 0.69–14.7, p = 0.1 for treatment success in patients that received combination therapy over those that received monotherapy].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.